NO903666L - Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser. - Google Patents

Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.

Info

Publication number
NO903666L
NO903666L NO90903666A NO903666A NO903666L NO 903666 L NO903666 L NO 903666L NO 90903666 A NO90903666 A NO 90903666A NO 903666 A NO903666 A NO 903666A NO 903666 L NO903666 L NO 903666L
Authority
NO
Norway
Prior art keywords
pyrrolokinol
compounds
procedure
preparation
pyrrolokinol compounds
Prior art date
Application number
NO90903666A
Other languages
English (en)
Other versions
NO903666D0 (no
Inventor
Masaaki Matsuo
Takashi Manabe
Hiroyuki Okumura
Hiroshi Matsuda
Naoaki Fujii
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO903666D0 publication Critical patent/NO903666D0/no
Publication of NO903666L publication Critical patent/NO903666L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO90903666A 1989-08-22 1990-08-21 Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser. NO903666L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898919091A GB8919091D0 (en) 1989-08-22 1989-08-22 Pyrroloquinoline compounds
GB909003252A GB9003252D0 (en) 1989-08-22 1990-02-13 Pyrroloquinoline compounds

Publications (2)

Publication Number Publication Date
NO903666D0 NO903666D0 (no) 1990-08-21
NO903666L true NO903666L (no) 1991-02-25

Family

ID=26295800

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903666A NO903666L (no) 1989-08-22 1990-08-21 Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.

Country Status (15)

Country Link
US (1) US5164400A (no)
EP (1) EP0414023A3 (no)
JP (1) JPH0386882A (no)
KR (1) KR910004636A (no)
CN (1) CN1049663A (no)
AU (1) AU6001290A (no)
CA (1) CA2023726A1 (no)
FI (1) FI904138A0 (no)
GB (2) GB8919091D0 (no)
HU (1) HUT55015A (no)
IE (1) IE902590A1 (no)
IL (1) IL95088A0 (no)
NO (1) NO903666L (no)
PT (1) PT95052A (no)
ZA (1) ZA906102B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
JPH0565748U (ja) * 1992-02-21 1993-08-31 株式会社ユニシアジェックス 後輪操舵装置
WO1999020632A1 (fr) * 1997-10-23 1999-04-29 Takeda Chemical Industries, Ltd. Derives d'imidazopyridine condenses, leur procede de production et preparations les renfermant
KR100385673B1 (ko) * 2001-08-17 2003-06-02 신의승 회전추를 이용한 휴대가 간편한 원판 운동기구
US8563567B2 (en) 2009-12-30 2013-10-22 Arqule, Inc. Substituted heterocyclic compounds
CN108752340B (zh) * 2018-07-18 2020-09-01 山东中医药大学附属医院 吡咯并喹啉衍生物及其在治疗心律失常中的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
WO1984002131A1 (en) * 1982-11-22 1984-06-07 Sandoz Ag Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals

Also Published As

Publication number Publication date
CN1049663A (zh) 1991-03-06
IL95088A0 (en) 1991-06-10
KR910004636A (ko) 1991-03-29
NO903666D0 (no) 1990-08-21
FI904138A0 (fi) 1990-08-21
AU6001290A (en) 1991-02-28
HU905089D0 (en) 1991-01-28
US5164400A (en) 1992-11-17
GB8919091D0 (en) 1989-10-04
PT95052A (pt) 1991-04-18
GB9003252D0 (en) 1990-04-11
EP0414023A3 (en) 1991-11-06
CA2023726A1 (en) 1991-02-23
IE902590A1 (en) 1991-02-27
EP0414023A2 (en) 1991-02-27
ZA906102B (en) 1991-05-29
JPH0386882A (ja) 1991-04-11
HUT55015A (en) 1991-04-29

Similar Documents

Publication Publication Date Title
NO900830D0 (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO904987L (no) Fremgangsmaate for fremstilling av indolderivater.
NO905008L (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO902003L (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO901554L (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO904285L (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO903431L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO892204L (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO905377L (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO903043D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903207D0 (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO913692D0 (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO903666L (no) Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.
NO901067D0 (no) Fremgangsmaate for fremstilling av tiofener.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO904535D0 (no) Fremgangsmaate for fremstilling av fenoxy-heterocykliske forbindelser.
NO904060D0 (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO905047L (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO904070L (no) Fremgangsmaate for fremstilling av alkanfenoner.
NO890538D0 (no) Fremgangsmaate for fremstilling av oxadiazolyl-azabicyclo-heptaner.
NO920207L (no) Fremgangsmaate for fremstilling av 6-methyl-oestra-4,6-diener
NO913089L (no) Fremgangsmaate for fremstilling av tetrazolforbindelser.
NO904362L (no) Fremgangsmaate for fremstilling av kromanderivater.